Tokyo Tape
Sign in
← Chiome Bioscience

Quarterly report · Q2

4583.TEDINET S100OXYH
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥278m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥713m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥385m2021-01-01 → 2021-06-30StandaloneNet sales
Operating income−¥779m2022-01-01 → 2022-06-30StandaloneOperating income
Operating income−¥415m2021-01-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥769m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥409m2021-01-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥769m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥397m2021-01-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥771m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥409m2021-01-01 → 2021-06-30StandaloneProfit loss
Total assets¥1.9bnat 2022-06-30StandaloneAssets
Total assets¥2.3bnat 2021-12-31StandaloneAssets
Total assets¥3.3bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥444mat 2022-06-30StandaloneLiabilities
Total liabilities¥446mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2022-06-30StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.9bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥1.8bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2021-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2020-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥660m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥561m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥35m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥341m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥271m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥176m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-18.172022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.532022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.742021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.162021-01-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.162021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio75.3%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.3%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued43,057,600at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,781,500at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued40,291,500at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥239m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥691m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-06-30¥151m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥540m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30−¥215m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentrevenue2021-01-01 → 2021-06-30¥103m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentrevenue external2021-01-01 → 2021-06-30¥103m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2021-01-01 → 2021-06-30−¥356m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2021-01-01 → 2021-06-30¥282m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2021-01-01 → 2021-06-30¥282m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2021-01-01 → 2021-06-30¥156m
Total Of Reportable Segments And Otherssegment totalrevenue2021-01-01 → 2021-06-30¥385m
Total Of Reportable Segments And Otherssegment totalrevenue external2021-01-01 → 2021-06-30¥385m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-06-30−¥201m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 436
ItemContextValueUnit
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember1471935000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember25456000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember68403000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember59049000JPY
InventoriesCurrentQuarterInstant_NonConsolidatedMember65974000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember270440000JPY
Advance payments tradeCurrentQuarterInstant_NonConsolidatedMember113245000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember36050000JPY
Consumption taxes receivableCurrentQuarterInstant_NonConsolidatedMember20653000JPY
Other caPrior1YearInstant_NonConsolidatedMember34898000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember51887000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember2216883000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember1792100000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember291571000JPY
Machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember257893000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-287372000JPY
Accumulated depreciation machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember-254741000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember4199000JPY
Machinery and equipment netCurrentQuarterInstant_NonConsolidatedMember3151000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember95820000JPY
Tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember97242000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-95820000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember-97242000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netCurrentQuarterInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember4199000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember3151000JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember5544000JPY
Long term prepaid expensesCurrentQuarterInstant_NonConsolidatedMember12148000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember112811000JPY
Lease and guarantee depositsCurrentQuarterInstant_NonConsolidatedMember112811000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember118355000JPY
Investments and other assetsCurrentQuarterInstant_NonConsolidatedMember124959000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember122555000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember128111000JPY
AssetsPrior1YearInstant_NonConsolidatedMember2339439000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember1920212000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember29809000JPY
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember46089000JPY
Short term loans payablePrior1YearInstant_NonConsolidatedMember183000000JPY
Short term loans payableCurrentQuarterInstant_NonConsolidatedMember188000000JPY
Accounts payable otherPrior1YearInstant_NonConsolidatedMember81549000JPY
Accounts payable otherCurrentQuarterInstant_NonConsolidatedMember90534000JPY
Accrued expensesPrior1YearInstant_NonConsolidatedMember39636000JPY
Accrued expensesCurrentQuarterInstant_NonConsolidatedMember28214000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember16745000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember16185000JPY
Advances receivedPrior1YearInstant_NonConsolidatedMember30523000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass